Cardiovascular Medicine
Research activity includes acute myocardial infarction and recurrent ischemic risk, with interest in early symptom-driven intervention and outcomes in patients vulnerable to another cardiac event.
- Acute myocardial infarction
- Recurrent myocardial ischemia
- Symptom-triggered treatment
The cardiovascular portfolio centers on emergency cardiac care and prevention of further infarction in high-risk populations.
Autoimmune and Rheumatologic Disease
Clinical research focuses on systemic lupus erythematosus, including moderate to severe disease and longer-term disease control in adults receiving background therapy.
- Systemic lupus erythematosus
- Moderate to severe autoimmune disease
- Disease activity reduction
The work reflects sustained interest in controlling inflammatory activity and improving management of chronic autoimmune disorders.
Immunomodulatory Therapeutics
Trials examine oral therapies directed at immune-mediated disease, with emphasis on treatment effects in lupus and maintenance of tolerability during continued use.
- Immune system modulation
- Oral immunotherapy
- Long-term tolerability
This area highlights therapeutic development for chronic inflammatory conditions requiring ongoing disease management.
Clinical Pharmacology
Research also includes evaluation in healthy volunteers, supporting characterization of drug behavior and exposure in humans.
- Healthy volunteer studies
- Bioavailability assessment
- Human pharmacokinetics
These studies contribute to the understanding of how candidate medicines are absorbed and handled in the body.
